Modulation of miR-21 signaling by MPS1 in human glioblastoma

Uday B Maachani1, Anita Tandle1, Uma Shankavaram1

  • 1Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Oncotarget
|May 21, 2015
PubMed

Insights

Monopolar spindle 1 (MPS1) kinase inhibition upregulates tumor suppressors PDCD4 and MSH2 by downregulating miR-21 in glioblastoma. This reveals a potential therapeutic strategy targeting MPS1 and miR-21 for glioblastoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Monopolar spindle 1 (MPS1) is a crucial kinase for spindle assembly checkpoint and has roles beyond mitosis.
  • Earlier research highlighted MPS1's involvement in glioblastoma (GBM) radiosensitization.
  • Elevated microRNA-21 (miR-21) expression in GBM correlates with chemo- and radioresistance.

Purpose of the Study:

  • To investigate MPS1-mediated cell signaling pathways in GBM.
  • To explore the relationship between MPS1, miR-21, and GBM cell proliferation.
  • To elucidate the prognostic significance of miR-21, PDCD4, and MSH2 in GBM.

Main Methods:

  • Utilized reverse phase protein arrays (RPPAs) to analyze MPS1-mediated signaling.
  • Assessed the impact of MPS1 inhibition on PDCD4, MSH2, and miR-21 expression.
  • Investigated the effect of MPS1 and miR-21 modulation on GBM cell proliferation.
  • Examined MPS1's role in SMAD3/SMAD2 phosphorylation.

Main Results:

  • MPS1 inhibition upregulated tumor suppressors PDCD4 and MSH2 by downregulating miR-21.
  • Both MPS1 and miR-21 depletion suppressed GBM cell proliferation.
  • Ectopic miR-21 expression rescued GBM cell growth upon MPS1 inhibition.
  • MPS1 mediated SMAD3 phosphorylation, suggesting a mechanism for miR-21 regulation.
  • miR-21, PDCD4, and MSH2 levels showed prognostic value in GBM subtypes.

Conclusions:

  • MPS1 plays a significant role in TGF-β/SMAD signaling through miR-21 regulation in GBM.
  • Targeting MPS1 and modulating miR-21 presents a potential therapeutic strategy for GBM.
  • Understanding the interplay of MPS1, miR-21, and tumor suppressors offers new avenues for GBM treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K